Navigation Links
UniCare Announces Temporary Pharmacy Guidelines for Customers Affected by the California Wildfires
Date:10/26/2007

CHICAGO, Oct. 26 /PRNewswire/ -- UniCare announced today a policy to make it easy for members affected by the wildfires in southern California to get the prescription drugs they need.

A one-time override for a 30-day supply of medication will be set up so that UniCare policyholders in the affected counties can continue their medication without interruption. This temporary policy will be in place for members living in Los Angeles, Orange, San Bernardino, San Diego and Santa Barbara Counties.

"We are very concerned for the people of California and saddened by the impact of these wildfires," said Dennis Casey, president and CEO of UniCare. "It's important that we adjust our pharmacy guidelines to help meet the health care needs of our members in the affected counties."

UniCare members affected by the wildfires should seek medical care at the nearest emergency facility. If a member has lost a prescription, he or she should have the medication filled at any UniCare network pharmacy. Members who utilize mail order service for prescription refills should contact Prescription Rx at 1-866-274-6826 and provide an alternate address if they have been displaced from their home.

For additional questions, members should contact a UniCare customer service advocate using the toll free number on the back of their UniCare ID card. Members who have lost their ID card should call 877-UNICARE for assistance.

UniCare is a national operating subsidiary of WellPoint, Inc., the largest publicly traded commercial health benefits company in terms of membership in the United States. UniCare can be found on the web at http://www.unicare.com.

Not all UniCare products are available in all states where UniCare is marketed. Insurance or health maintenance organization coverage is provided by any of the following: UniCare Life & Health Insurance Company, UniCare Health Insurance Company of the Midwest (IN an
'/>"/>

SOURCE UniCare
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...gist and a radiation oncologist at Memorial Sloan-...f the physician patients see can influence the ty...nalyzed men with localized prostate cancer. It fou...ologist are more likely to undergo surgery to remo...
...announced follow-up data from a Phase 2 clinical t...hich was conducted by the Johns Hopkins Sidney Kim... with operable pancreatic cancer who received GVAX...vant radiation and chemotherapy. The median overal...
...terpret confusing situations or those that may pos...rchers from the Mouse Biology Unit of the Europea...covered the neural basis for such anxiety behaviou...rent issue of Nature Neuroscience, states that cru...
...ve of the underdeveloped countries is old hat by n...ting hospital infection. Only a few days ago it wa...k patient in England complained he had been left l...few hours. But some time governments in the devel...
Other Medicine News:Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 2Health News:Early Prostate Cancer: Specialty of Physician Influences Type of Therapy Received 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Neural Basis of Anxiety: Newer Insights 2Health News:Crackdown on Dirty Hospitals in UK 2Health News:Crackdown on Dirty Hospitals in UK 3
(Date:10/8/2008)...inical improvement in patients with pulmonary ...ent options have limited benefit for this debilita... vessel disease, -- Imatinib mesylate, availabl...ers, known to inhibit protein associated with PAH,...atinib mesylate in PAH in 2009 EAST HANOVER,...
(Date:10/7/2008)...wire/ -- The Texas Cardiac Arrhythmia,Institute (T...ed as one of,only a few sites in the nation to par...ew device to treat persistent atrial fibrillation....search center specializing in heart,rhythm disorde...enter and,Texas Cardiovascular Consultants., "Thi...
(Date:10/7/2008)...re-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM )...al Transfer,Agreement (MTA) with the National Inst...aboratory of Dr. Francesco M. Marincola, M.D., to,...tumor microenvironment,caused by CEL-SCI,s cancer ...Infectious Disease and Immunogentics Section, Depa...
(Date:10/7/2008)...ewswire/ -- Taligen Therapeutics Inc.,today announ...pipeline,candidates were presented at the XXII Int...nd. The data highlighted the candidates, efficacy ...seases., "These highlighted presentations, as wel...ference, reveal the deep expertise and expanding,k...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 1Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 2Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 1ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 2ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 4Lilly and Amylin Set Date and Time for Conference Call 25766 1Lilly and Amylin Set Date and Time for Conference Call 25766 2AgriLife Research breeder develops drought tolerant corn 4604 1AgriLife Research breeder develops drought tolerant corn 4604 2
... MINNEAPOLIS--(BUSINESS WIRE)--Mar 27, 2007 - Acco..., nearly 80 percent of the American,public does no...abetes. The survey, conducted by Harris Interactiv...), showed that almost half,of respondents were als...ted. The results of the survey, particularly those...
... LANSING, Mich., March 27, 2007 /PRNewswire/ -- A...positive results on,the ability of its new triple ...ections of mammalian cells. The audited results we...party testing,organization. The new viral sequestr...iruses by 3 critical mechanisms thus blocking,infe...
Other Medicine Technology:Survey Reveals Significant Public Lack of Diabetes Awareness 2Survey Reveals Significant Public Lack of Diabetes Awareness 3Survey Reveals Significant Public Lack of Diabetes Awareness 4Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents 2
Laser hair removal for all skin types, including tanned skin. Used for leg and facial veins, non-invasive skin treatment. Offers a large spot sizes with high repetition rates for fast treatment. A
The Soft THORACOPORT™ has a cannula that is less rigid from a side to side perspective than the standard THORACOPORT™ , ,THORACOPORT™ devices are trocars used to gain access to th
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System.
VersaStep™ Reposable Sterilization Trays.
Medicine Products: